[{"section_title": "Overview", "text": "\u2022 Throughout 1990s concern expressed regarding workforce outcomes for early career biomedical scientists \u2022 In late 1990s, NIH budget began an expansion that resulted in a doubling of the budget over a 5-year period \u2022 Here we examine the effects of this doubling on careers of young life scientists   5 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Year T ime to Degree Tenure track status is for those trained in U.S. Source: Survey of Doctorate Recipients, NSF. The use of NSF data does not imply NSF endorsement of the research methods or conclusions contained in this report. 1993 1995 1997 1999 2001 2003 Unemployed Slide is for those trained in the U.S. Source: Survey of Doctorate Recipients, NSF. The use of NSF data does not imply NSF endorsement of the research methods or conclusions contained in this report."}, {"section_title": "Labor Force Status: Biomedical PhDs", "text": ""}, {"section_title": "Summary", "text": "\u2022 See growth in hiring of individuals trained in the U.S. among medical colleges during the decade relative to non-medical colleges \u2022 Change in mix of tenure and tenure track -33% of medical faculty were in non-tenure track positions in 1993; -45% were in non-tenure track positions in 2003. \u2022 Considerable growth in hiring at medical colleges during the NIH doubling period 1 9 8 0 1 9 8 1 1 9 8 2 1 9 8 3 1 9 8 4 1 9 8 5 1 9 8 6 1 9 8 7 1 9 8 8 1 9 8 9 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 0 0 0 2 0 0 1 2 0 0 2 2 0 0 3 2 0 0 4 2 0 0 5 "}, {"section_title": "MD", "text": ""}, {"section_title": "NIH Primer", "text": "\u2022 R01 is basic grant for independent research; in earlier years R29 existed as the \"first\" independent award for new investigators. Duration of three to five years. \u2022 Type 1 is a new application \u2022 Type 2 is a continuing application \u2022 Type 1's can be from \"new\" investigators who have never been funded or from established investigators \u2022 Review process: triage-group that is not scored; possible to submit up to two amendments; can resubmit even if not scored. 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 0 0 0 2 0 0 1 2 0 0 2 2 0 0 3 2 0 0 4 2 0 0 5 Number of NIH Competing R01 Equivalent* Applicants Reviewed, Awarded, and Percent Funded (Success Rate) -1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 0 0 0 2 0 0 1 2 0 0 2 2 0 0 3 2 0 0 4 2 0 0 5 10,000 12,000 14,000 16,000 18,000 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 0 0 0 2 0 0 1 2 0 0 2 2 0 0 3 2 0 0 4 2 0 0 5 2 0 0 6 Review Year "}]